Literature DB >> 3002608

Role of epidermal growth factor in carcinogenesis.

C M Stoscheck, L E King.   

Abstract

For cell growth and division to occur, a large variety of metabolic processes must be carefully coordinated in the cell. Through evolutionary pressures, specific hormones and growth factors have acquired the ability to trigger a complex coordinated "pleiotropic growth response" in their target cells. This complex response is mediated by specific cellular receptors and intracellular messengers. Teleologically then, it makes sense that in oncogenesis this growth regulating network is utilized by the production of proteins which mimic growth factors, the activated form of their receptors or, the messengers themselves. Several lines of evidence indicate that the epidermal growth factor-stimulated growth regulatory system is involved in cellular proliferation, both normal and neoplastic. Some of the effects of epidermal growth factor in carcinogenesis are separable from its direct, growth stimulatory effects. Thus, the role of epidermal growth factor in carcinogenesis is more complex than is its role in stimulating growth.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3002608

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

Review 1.  Biochemical study of cyst fluid in human breast cystic disease: a review.

Authors:  C L Enriori; J E Novelli; M del C Cremona; R J Hirsig; P J Enriori
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 2.  The role of growth factors in the pituitary.

Authors:  S Ezzat; S Melmed
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

3.  Two classes of continuous cell lines established from Syrian hamster 9 day gestation embryos: preneoplastic cells and progenitor cells.

Authors:  T Okeda; Y Yokogawa; H Ueo; M A Bury; P O Ts'o; S A Bruce
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

Review 4.  Angiogenic growth factors in neural embryogenesis and neoplasia.

Authors:  D Zagzag
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 5.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

6.  The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.

Authors:  M Onda; A Tokunaga; K Nishi; T Yoshiyuki; Y Shimizu; T Kiyama; T Mizutani; N Matsukura; N Tanaka; K Yamashita
Journal:  Jpn J Surg       Date:  1990-05

7.  Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells.

Authors:  M B Meyers; V J Merluzzi; B A Spengler; J L Biedler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.

Authors:  M H Werner; P A Humphrey; D D Bigner; S H Bigner
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.

Authors:  K Z Ching; E Ramsey; N Pettigrew; R D'Cunha; M Jason; J G Dodd
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

10.  Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

Authors:  E M Hiesiger; R L Hayes; D M Pierz; G N Budzilovich
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.